| Reaction Details |
|---|
 | Report a problem with these data |
| Target | C-C chemokine receptor type 2 |
|---|
| Ligand | BDBM50091464 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEBML_41896 |
|---|
| Ki | 4400±n/a nM |
|---|
| Citation |  Forbes, IT; Cooper, DG; Dodds, EK; Hickey, DM; Ife, RJ; Meeson, M; Stockley, M; Berkhout, TA; Gohil, J; Groot, PH; Moores, K CCR2B receptor antagonists: conversion of a weak HTS hit to a potent lead compound. Bioorg Med Chem Lett10:1803-6 (2000) [PubMed] |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| C-C chemokine receptor type 2 |
|---|
| Name: | C-C chemokine receptor type 2 |
|---|
| Synonyms: | C-C chemokine receptor type 2 (CCR2) | CCR2 | CCR2_HUMAN | CMKBR2 | Chemoattractant Cytokine Receptor 2 (CCR2) | Chemokine Receptor Type 2b (CCR2b) | Monocyte chemotactic protein-1 (MCP-1) |
|---|
| Type: | Enzyme |
|---|
| Mol. Mass.: | 41932.32 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | P41597 |
|---|
| Residue: | 374 |
|---|
| Sequence: | MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGN
MLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLY
HIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTK
CQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHR
AVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCI
NPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSI
GRAPEASLQDKEGA
|
|
|
|---|
| BDBM50091464 |
|---|
| n/a |
|---|
| Name | BDBM50091464 |
|---|
| Synonyms: | 2-(3,4-Dichloro-phenyl)-N-{5-[4-(1H-indol-3-yl)-piperidin-1-yl]-pentyl}-acetamide | CHEMBL53779 | N-(5-(4-(1H-indol-3-yl)piperidin-1-yl)pentyl)-2-(3,4-dichlorophenyl)acetamide |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C26H31Cl2N3O |
|---|
| Mol. Mass. | 472.45 |
|---|
| SMILES | Clc1ccc(CC(=O)NCCCCCN2CCC(CC2)c2c[nH]c3ccccc23)cc1Cl |
|---|
| Structure | 
|
|---|
Search and Browse
